Chemistry:Enlicitide chloride

From HandWiki
Short description: Chemical compound


Enlicitide chloride
Identifiers
CAS Number
PubChem CID
UNII
Chemical and physical data
FormulaC82H110ClFN14O15
Molar mass1586.31 g·mol−1
3D model (JSmol)

Enlicitide chloride (INN;[1] previously known as MK-0616) is a macrocyclic peptide investigational drug that is being evaluated for the treatment of hypercholesterolaemia. It is a PCSK9 inhibitor.[2]

Merck has launched a Phase 3 clinical trial to evaluate the efficacy and safety of MK-0616 in Adults With Hypercholesterolemia. [3][4]


References